We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Ethanolamine Is a New Anti-Prion Compound.
- Authors
Uchiyama, Keiji; Hara, Hideyuki; Chida, Junji; Pasiana, Agriani Dini; Imamura, Morikazu; Mori, Tsuyoshi; Takatsuki, Hanae; Atarashi, Ryuichiro; Sakaguchi, Suehiro
- Abstract
Prion diseases are a group of fatal neurodegenerative disorders caused by accumulation of proteinaceous infectious particles, or prions, which mainly consist of the abnormally folded, amyloidogenic prion protein, designated PrPSc. PrPSc is produced through conformational conversion of the cellular isoform of prion protein, PrPC, in the brain. To date, no effective therapies for prion diseases have been developed. In this study, we incidentally noticed that mouse neuroblastoma N2a cells persistently infected with 22L scrapie prions, termed N2aC24L1-3 cells, reduced PrPSc levels when cultured in advanced Dulbecco's modified eagle medium (DMEM) but not in classic DMEM. PrPC levels remained unchanged in prion-uninfected parent N2aC24 cells cultured in advanced DMEM. These results suggest that advanced DMEM may contain an anti-prion compound(s). We then successfully identified ethanolamine in advanced DMEM has an anti-prion activity. Ethanolamine reduced PrPSc levels in N2aC24L1-3 cells, but not PrPC levels in N2aC24 cells. Also, oral administration of ethanolamine through drinking water delayed prion disease in mice intracerebrally inoculated with RML scrapie prions. These results suggest that ethanolamine could be a new anti-prion compound.
- Subjects
PRION diseases; PRIONS; DRINKING water; NEURODEGENERATION; SCRAPIE; VACCINATION; MOUSE diseases
- Publication
International Journal of Molecular Sciences, 2021, Vol 22, Issue 21, p11742
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms222111742